Viewing Study NCT06168500



Ignite Creation Date: 2024-05-06 @ 7:51 PM
Last Modification Date: 2024-10-26 @ 3:15 PM
Study NCT ID: NCT06168500
Status: RECRUITING
Last Update Posted: 2024-05-29
First Post: 2023-11-15

Brief Title: Narrow Implants Vs Standard Implants With Simultaneous GBR
Sponsor: Universitat Internacional de Catalunya
Organization: Universitat Internacional de Catalunya

Study Overview

Official Title: Narrow Diameter Implants Versus Standard Diameter Implants With Simultaneous Bone Regeneration For The Treatment Of Atrophic Posterior Area
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: NDI represent an advisable treatment option when the mesio-distal space is compromised In a recent retrospective study with a follow-up of 8 years in which they wanted to evaluate the long-term survival complications peri-implant conditions marginal bone loss and patient satisfaction of fixed dental prostheses supported by NDI in the posterior area They observe a survival rate of 97 and absence of prosthetic complications after the study period time More recently Souza et al performed a prospective randomized split mouth study with 3 years follow-up with the aim of comparing marginal bone level implant survival and success rates and prosthesis success rates of NDI and SDI placed in the posterior area of the mandible to support single prosthesis They observed an implant survival rate of 100 for both groups at 1 and 3 years The prosthesis success rate at 1 and 3 years was of 954 and 100 respectively

NDI present a high survival rate on the evaluated studies Therefore the aim of the first study is to compare the patient related outcomes implants and prostheses success and survival rates of pure titanium NDI versus SDI with simultaneous bone regeneration in narrow alveolar ridges at posterior areas of the maxilla and the mandible
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None